Nasal polyposis, Canevari (Iar): “We work on precision solutions”

The professor at the San Martino hospital at the University of Genoa and president of the Italian Academy of Rhinology (Iar), declared it on the sidelines of the Gsk meeting ‘New frontiers in CRSwNP: precision therapy with mepolizumab’,

Multidisciplinarity is the essence of medicine. If we didn’t work with the ‘neighbors’, i.e. with colleagues from different disciplines, we could not have adequate therapy for patientsthe. Collaboration between specialists is even more important when it comes to biological drugs such as mepolizumab, already used for other aspects of the same chronic rhinosinusitis with nasal polyposis (CRSwNP). We must therefore take advantage of the experience that comes to us from our immunologist, pulmonologist and allergist colleagues, and we must work to identify an optimal therapeutic path for each patient. There are many biological drugs, today we ask ourselves which one to use for each individual patient. This is precision medicine.” He said it Frank Rikki Mauritz Canevari, professor at the San Martino hospital of the University of Genoa and president of the Italian Academy of Rhinology (Iar), on the sidelines of the Gsk meeting ‘New frontiers in CRSwNP: precision therapy with mepolizumab’, which took place in the context of the 109th National Congress of the Sio (Italian Society of Otorhinolaryngology and Head and Neck Surgery), underway until tomorrow in Milan.

“The Pdta (diagnostic therapeutic care pathway) was born from the Italian Academy of rhinology – explained the president of the Iar – and was adopted by the Liguria Region both to have a prescriptive appropriateness and with a view to saving money. It is a virtuous model, which is about to be copied by various Regions, including Lazio and Lombardy.It provides for multidisciplinary work, the correct phenotyping and endotyping of the patient at the baseline, but not only: the Pdta also describes how the patient must be followed up time. This attitude must be adopted by all specialists, so that these patients, who have many serious problems, can be followed up rigorously”.



Source-www.adnkronos.com